Position in BTAI
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$54,940
-$10,660 QoQ
Shares Held
41,000
0.0% QoQ
Ownership
0.133%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 40 holders
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BTAI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026HighTower Advisors, LLC holds $76,791,783 across 32 Drug Manufacturers - Specialty & Generic names. BTAI ranks #30 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
419,904 | $49,636,851 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
224,067 | $6,748,898 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
4,894 | $2,902,044 | |
| 4 | HLN |
Haleon plc
|
192,177 | $1,923,691 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
103,082 | $1,909,078 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
11,198 | $1,475,224 | |
| 7 | VTRS |
Viatris Inc
|
108,052 | $1,459,782 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
93,386 | $1,160,787 |
All Filings in BTAI
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $54,940 | 41,000 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $65,600 | 41,000 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $89,600 | 35,000 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $44,526 | 24,600 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||